Security key
702712100
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)
CUSIP: 702712100
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 36,319,532
- Total 13F value
- $12,823,290
- Share change
- -1,310,188
- SEC-reported price per share
- $0.35
- Number of holders
- 40
- Value change
- -$494,907
- Number of buys
- 13
- Number of sells
- 17
- Shares outstanding
- 3,208,376
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
40
Top holders
10
PASG full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Passage BIO, Inc. SEC filings
Passage BIO, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 702712100
Recent filing periods:
Ownership snapshot
Top reported holders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Erste Asset Management GmbH
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
13D/G
Lead comparable stake: 4.4%
13D/G row: Erste Asset Management GmbH
Showing 1-6 of 15 holder rows.
Quick read
Erste Asset Management GmbH leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Erste Asset Management GmbH's linked filing trail.
Comparable ownership
Top 5
Erste Asset Management GmbH
4.4%
Lynx1 Capital Management LP
289%
ORBIMED ADVISORS LLC
231%
Vestal Point Capital, LP
190%
New Leaf Venture Partners, L.L.C.
78%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Erste Asset Management GmbH |
13F
13D/G
Company
|
4.4%
from 13D/G
|
$1,632,661
2,455,800 shares
|
— | 31 Dec 2024 |
| Lynx1 Capital Management LP |
13F
Company
|
289%
|
$5,249,618
9,256,953 shares
|
— | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
231%
|
$4,199,301
7,404,869 shares
|
— | 31 Dec 2024 |
| Vestal Point Capital, LP |
13F
Company
|
190%
|
$3,459,310
6,100,000 shares
|
— | 31 Dec 2024 |
| New Leaf Venture Partners, L.L.C. |
13F
Company
|
78%
|
$1,416,322
2,497,922 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
65%
|
$1,174,562
2,071,538 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
40
Shares
36,319,532
Rows available
40
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
40
Q1 2025 holders
40
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend